Dr. Alan & Diane Breier PARC is dedicated to furthering the understanding of the causes of psychosis and developing new, more effective treatment alternatives. As a center of research excellence, Dr. Alan & Diane Breier PARC partners with the Indiana University Psychotic Disorders Program (IUPDP) to conduct cutting-edge clinical trials of novel therapeutics for psychosis. Additionally, neuroimaging technologies are used to investigate the roles of brain structure, function and metabolism in illness occurrence. Since opening, the program has enrolled hundreds of young individuals with early psychosis for treatment, many of whom also participate in research studies.
Research conducted includes surveys and questionnaires, medication trials, psychotherapy trials, brain imaging, repetitive transcranial stimulation and genetic studies. Research helps to develop new drugs to help fight disease and illness, and every participant is important in reaching those goals. Participants receive excellent medical care, may receive study procedures at no cost and are often paid for their time. Participation in research is voluntary.
A physician reviews volunteers’ medical history, and the research team answers questions and determines if they qualify. Patients can discontinue participation at any time, and volunteering does not affect their clinical care.
If you or someone you know if interested in participating in a research program, please call
317.880.8495.